diallyl urea | 1801-71-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 英文名称: diallyl urea
• 英文别名: N,N-diallyl-urea；N,N-Diallyl-harnstoff；diallylurea；N,N-Diallyl-harnstoff；N,N-Diprop-2-en-1-ylurea；1,1-bis(prop-2-enyl)urea
• CAS: 1801-71-4
• 化学式: C₇H₁₂N₂O
• 分子量: 140.185
• InChiKey: IBZFWQBTUHEPOW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  甲醇 、 diallyl urea 、 mercury(II) diacetate 在 sodium hydroxide 、 sodium chloride 作用下， 生成 2,2'-dimethoxy-3,3'-carbamoylimino-bis-propylmercury (1+); dichloride
  参考文献：
  名称：

  Construction and expression of retroviruses encoding dual drug resistance genes in human umbilical cord blood CD34+ cells

  摘要：

  A series of retroviral vectors encoding human mdr1 gene alone as well as in combination with either human mgmt gene or human mutant Ser(31)-dhfr gene are engineered. The resultant retroviruses are used to transduce human umbilical cord blood CD34(+) cells. It has been shown that expression of dual drug resistance genes in transduced cells confers a broad range of resistance to both kinds of corresponding drugs. These data suggest a rationale for the use of such double chemoresistance gene constructs in an in vivo model in which transduced hematopoietic cells will acquire multiple protection against the cytotoxic side effects of combination chemotherapy and may have future application in chemoprotection of normal tissues, thus killing tumor cells more effectively.

  DOI：

  10.1007/bf02886244
• 作为产物：
  描述：

  二烯丙基代氰氨 在 1,4-二氧六环 、 硫酸 作用下， 生成 diallyl urea
  参考文献：
  名称：

  取代基对取代氰胺在硫酸溶液中水解的影响

  摘要：

  已确定单取代和双取代氰胺在 20% 硫酸溶液中水解的能量和活化熵。这些动力学数据清楚地显示了取代基的影响，并且将取代基分为三组，(1) 被取代的正烷基，(2) 被取代的支链烷基和 (3) 被不饱和基团取代的氰胺。氰胺水解所需的活化能的差异可以通过假设中间体氰胺二硫酸盐来解释，决定速率的步骤是氰胺的第二次质子化以产生氰胺二硫酸盐。

  DOI：

  10.1246/bcsj.27.416

文献信息

• [EN] POLYCATIONIC AMPHIPHILES AND POLYMERS THEREOF AS ANTIMICROBIAL AGENTS AND METHODS USING SAME<br/>[FR] COMPOSÉS AMPHIPHILES POLYCATIONIQUES ET LEURS POLYMÈRES UTILISABLES EN TANT QU'AGENTS ANTIMICROBIENS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  公开号：WO2016172436A1

  公开（公告）日：2016-10-27

  The present invention includes novel polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes novel polymers of polycationic amphiphilic compounds useful as antimicrobial agents. The present invention further includes methods useful for removing microorganisms and/or biofilm-embedded microorganisms from a surface. The present invention further includes compositions and methods useful for preventing or reducing the growth or proliferation of microorganisms and/or biofilm-embedded microorganisms on a surface.

  本发明包括新型的具有抗菌作用的多阳离子两性化合物。本发明还包括新型的多阳离子两性化合物聚合物，用作抗菌剂。本发明还包括用于从表面去除微生物和/或生物膜中嵌入的微生物的方法。本发明还包括用于预防或减少微生物和/或生物膜中嵌入的微生物在表面上生长或繁殖的组合物和方法。
• 5-HT2B receptor antagonists
  申请人：——

  公开号：US20040010022A1

  公开（公告）日：2004-01-15

  The present invention relates to compounds of formula I: 1 wherein one of R 1 and R 4 is selected from the group consisting of H, and optionally substituted C 1-6 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl-C 1-4 alkyl, and phenyl-C 1-4 alkyl; and the other of R 1 and R 4 is an optionally substituted C 9-14 aryl group; R 2 and R 3 are either: (i) independently selected from H, R, R′, SO 2 R, C(═O)R, (CH 2 ) n NR 5 R 6 , where n is from 1 to 4 and R 5 and R 6 are independently selected from H and R, where R is optionally substituted C 1-4 alkyl, and R′ is optionally substituted phenyl-C 1-4 alkyl, or (ii) together with the nitrogen atom to which they are attached, form an optionally substituted C 5-7 heterocyclic group; and their use as pharmaceuticals, in particular for treating conditions alleviated by the antagonism of a 5-HT 2B receptor.

  本发明涉及公式I的化合物： 1 其中R 1 和R 4 之一选自由H、以及可选地取代的C 1-6 烷基、C 3-7 环烷基、C 3-7 环烷基-C 1-4 烷基和苯基-C 1-4 烷基组成的组；R 1 和R 4 的另一个是可选地取代的C 9-14 芳基基团；R 2 和R 3 是： (i)独立地选自H、R、R′、SO 2 R、C(═O)R、(CH 2 ) n NR 5 R 6 ，其中n是从1到4，R 5 和R 6 独立地选自H和R，其中R是可选地取代的C 1-4 烷基，R′是可选地取代的苯基-C 1-4 烷基，或 (ii)与它们连接的氮原子一起，形成一个可选地取代的C 5-7 杂环基团；以及它们作为药物的使用，特别用于治疗通过5-HT 2B 受体的拮抗作用减轻的状况。
• HETEROCYCLIC COMPOUND
  申请人：Yoshikawa Masato

  公开号：US20130150344A1

  公开（公告）日：2013-06-13

  The present invention provides a compound represented by the formula (1): wherein each symbol is as defined in the specification, or a salt thereof, a prodrug of the compound or a salt thereof, a medicament containing the compound or a salt thereof, the medicament which is a phosphodiesterase 10A inhibitor, and a medicament which is for preventing or treating schizophrenia.

  本发明提供了一种由以下式（1）表示的化合物： 其中每个符号如规范中定义，或其盐，该化合物的前药或其盐，含有该化合物或其盐的药物，该药物是磷酸二酯酶10A抑制剂，以及用于预防或治疗精神分裂症的药物。
• USE OF SUBSTITUTED ISOQUINOLINONES, ISOQUINOLINDIONES, ISOQUINOLINTRIONES AND DIHYDROISOQUINOLINONES OR IN EACH CASE SALTS THEREOF AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS
  申请人：Frackenpohl Jens

  公开号：US20140302987A1

  公开（公告）日：2014-10-09

  Use of substituted isoquinolinones, isoquinolinediones, isoquinolinetriones and dihydroisoquinolinones of the general formula (I) or their respective salts where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress, for strengthening plant growth and/or for increasing plant yield, and selected processes for preparing the compounds mentioned above.

  使用通式（I）中的替代的异喹啉酮、异喹啉二酮、异喹啉三酮和二氢异喹啉酮或它们的相应盐，其中通式（I）中的基团对应于描述中给出的定义，用于增强植物对非生物胁迫的耐受性，增强植物生长和/或增加植物产量，并选择性地制备上述化合物的过程。
• Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
  申请人：Anderson Kevin William

  公开号：US20070225280A1

  公开（公告）日：2007-09-27

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

  本文提供了以下式（I）的化合物： 以及其药学上可接受的盐，其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物对于治疗诸如II型糖尿病和代谢综合征等疾病是有用的。